摘要
目的:探讨血管紧张素转换酶抑制剂(ACEI)在飞行员高血压患者群体中服用的安全性和有效性.方法:入选60例有高血压病的飞行员患者,每日口服盐酸贝那普利10mg,随访6个月,观察降压效果及不良反应.结果:治疗前收缩压平均为(149±4)mmHg,治疗后收缩压平均为(129±4)mmHg,两者比较有显著性差异;治疗前舒张压(88±3)mmHg,治疗后舒张压(78±3)mmHg,两者比较无显著性差异.其中2例出现干咳不良反应,无其他不良反应.结论:飞行员高血压病患者,选择血管紧张素转换酶抑制剂盐酸贝那普利长期服用是安全有效的.
Objective： Preliminary discussion on the safety and validity of ACEI in the treatment of pilot groups with hypertension.Methods： Test of blood pressure of 60 I - period hypertension pilots using ACEI, average dosage is 10mg everyday. In the 6 month interview, side effects and blood pressure drop are observed. Pomults： Systolic pressure before treatment≥ （149 ± 4） mmHg , but after treatment ≥ （ 129 ± 4 ） mmHg, obvious difference exists; diastolic pressure before treatment is （88 ± 3 ） mmHg, and after treatment is （78±3）mmHg, without obvious difference. 2 cases get cough （ 〈 2%） without other side effects.Conclusion： Usage of ACEI in long term is safe and valid for I - period hypertension pilots.
出处
《中国医药导刊》
2005年第4期283-283,285,共2页
Chinese Journal of Medicinal Guide
